← Back to Screener
Cencora, Inc. (COR)
Price$322.37
Favorite Metrics
Price vs S&P 500 (26W)-1.74%
Price vs S&P 500 (4W)-8.16%
Market Capitalization$62.71B
P/E Ratio (Annual)40.35x
Indicated Dividend Yield (Annual)0.76%
All Metrics
P/CF (Annual)16.18x
Book Value / Share (Quarterly)$9.81
P/TBV (Annual)7.70x
Indicated Dividend (Annual)$2.20
Revenue Growth (3Y)10.43%
Cash Flow / Share (Quarterly)$18.54
Payout Ratio (TTM)17.57%
Price vs S&P 500 (YTD)-8.61%
Gross Margin (TTM)3.63%
Net Profit Margin (TTM)0.50%
EPS (TTM)$8.31
10-Day Avg Trading Volume1.18M
EPS Excl Extra (TTM)$8.31
Revenue Growth (5Y)11.09%
EPS (Annual)$7.96
Dividend / Share (Annual)$2.25
ROI (Annual)16.95%
Gross Margin (Annual)3.51%
Net Profit Margin (5Y Avg)0.62%
Cash / Share (Quarterly)$9.01
P/E Basic Excl Extra (TTM)38.59x
Revenue Growth QoQ (YoY)5.45%
P/E Normalized (Annual)40.35x
ROA (Last FY)2.03%
Revenue Growth TTM (YoY)7.45%
EBITD / Share (TTM)$19.07
ROE (5Y Avg)278.25%
Operating Margin (TTM)0.82%
Cash Flow / Share (Annual)$16.54
P/B Ratio32.86x
P/B Ratio (Quarterly)34.33x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.21x
Net Interest Coverage (TTM)8.59x
ROA (TTM)2.17%
EPS Growth QoQ (YoY)14.47%
EV / EBITDA (TTM)18.54x
EPS Incl Extra (Annual)$7.96
Current Ratio (Annual)0.90x
Quick Ratio (Quarterly)0.50x
3-Month Avg Trading Volume1.31M
52-Week Price Return11.71%
EV / Free Cash Flow (Annual)21.48x
P/E Incl Extra (TTM)38.59x
Revenue / Employee (TTM)$6
Tangible BV / Share (Quarterly)$9.54
P/S Ratio (Annual)0.20x
Asset Turnover (Annual)4.20x
52-Week High$377.54
Operating Margin (5Y Avg)0.92%
EPS Excl Extra (Annual)$7.96
CapEx CAGR (5Y)12.56%
Tangible BV CAGR (5Y)-26.12%
26-Week Price Return2.24%
Quick Ratio (Annual)0.54x
13-Week Price Return-7.18%
Total Debt / Equity (Annual)5.08x
Current Ratio (Quarterly)0.92x
Enterprise Value$68,879.468
Revenue / Share Growth (5Y)12.19%
Asset Turnover (TTM)4.34x
Book Value / Share Growth (5Y)-10.80%
Revenue / Employee (Annual)$6
Inventory Turnover (Annual)15.70x
Pretax Margin (Annual)0.70%
Cash / Share (Annual)$22.46
3-Month Return Std Dev31.46%
Gross Margin (5Y Avg)3.37%
Net Income / Employee (TTM)$0
EBITDA Interim CAGR (5Y)9.49%
ROE (Last FY)103.06%
Net Interest Coverage (Annual)7.98x
EPS Basic Excl Extra (Annual)$7.96
P/FCF (TTM)10.27x
Receivables Turnover (TTM)12.21x
EV / Free Cash Flow (TTM)19.09x
Total Debt / Equity (Quarterly)4.15x
EPS Incl Extra (TTM)$8.31
Receivables Turnover (Annual)12.38x
ROI (TTM)17.07%
Dividend Growth Rate (5Y)6.10%
P/S Ratio (TTM)0.19x
Pretax Margin (5Y Avg)0.83%
Revenue / Share (Annual)$1646.05
Tangible BV / Share (Annual)$2.82
Forward P/E18.30x
Free OCF CAGR (5Y)11.79%
Price vs S&P 500 (52W)-18.12%
P/E Ratio (TTM)38.59x
EPS Growth TTM (YoY)18.29%
Year-to-Date Return-5.97%
5-Day Price Return-1.51%
EPS Normalized (Annual)$7.96
ROA (5Y Avg)2.55%
Net Profit Margin (Annual)0.48%
Month-to-Date Return1.10%
Cash Flow / Share (TTM)$13.26
EBITD / Share (Annual)$18.48
EPS Growth (3Y)-0.38%
Operating Margin (Annual)0.82%
LT Debt / Equity (Annual)5.00x
P/CF (TTM)14.62x
ROI (5Y Avg)22.74%
P/E Excl Extra (TTM)38.59x
LT Debt / Equity (Quarterly)3.97x
EPS Basic Excl Extra (TTM)$8.31
P/TBV (Quarterly)2.36x
Payout Ratio (Annual)28.12%
P/B Ratio (Annual)40.18x
Dividend / Share (TTM)$2.33
Inventory Turnover (TTM)14.08x
Pretax Margin (TTM)0.72%
Book Value / Share (Annual)$7.78
Price vs S&P 500 (13W)-7.87%
Dividend Yield (TTM)0.72%
Beta0.70x
P/FCF (Annual)19.55x
Revenue / Share (TTM)$1667.93
ROE (TTM)101.43%
52-Week Low$271.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.14
4.14
4.06
Industry Peers — Drug Wholesale(8)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Operating Margin (TTM) | Revenue Growth TTM (YoY) | Price |
|---|---|---|---|---|---|
CORCencora, Inc. | 40.35x | 101.43% | 0.82% | 7.45% | $322.37 |
MCKMcKesson Corporation | 32.34x | 39.43% | 1.42% | 15.49% | $867.34 |
CAHCardinal Health, Inc. | 32.10x | 37.17% | 1.04% | 10.13% | $213.10 |
HLFHerbalife Ltd. | 7.65x | 170.70% | -14.76% | 0.89% | $16.17 |
NUSNuSkin Enterprises, Inc. | 2.30x | 20.36% | 16.29% | -14.26% | $7.65 |
WGRXWellgistics Health, Inc. Common Stock | — | -1645.88% | -414.51% | 28.73% | $0.15 |
COSMCosmos Holdings Inc. Common Stock | — | -74.28% | -23.86% | 6.69% | $0.41 |
ZSTKZeroStack Corp. Common Stock | — | -332.01% | -339.14% | — | $6.91 |
HWHHWH International Inc. Common Stock | — | -88.53% | -326.05% | -30.84% | $1.17 |
About
Cencora is one of three dominant pharmaceutical wholesalers in the US, distributing branded, generic, and specialty drugs to pharmacies, hospitals, and healthcare providers. The company and its two main competitors control over 90% of the US pharmaceutical wholesale market. Beyond core distribution, Cencora generates revenue through commercialization services for pharmaceutical and medical device manufacturers, specialty logistics (World Courier), and animal health distribution (MWI Animal Health). The company strengthened its international footprint through the 2021 acquisition of Alliance Healthcare, a leading European pharmaceutical wholesaler.